Beta 2-agonists in asthma.

Beta 2-agonists in asthma.

Détails bibliographiques
Auteurs principaux:	Britton, J, Pavord, I, Wong, C, Tattersfields, A
Format:	Journal article
Langue:	English
Publié:	1991

Documents similaires

β2-agonists in asthma
par: Britton, J, et autres
Publié: (1991)

Asthma control during and after cessation of regular beta 2-agonist treatment.
par: Wahedna, I, et autres
Publié: (1993)

Use of long-acting beta2 agonists in arginine-16 homozygous patients with asthma.
par: Green, R, et autres
Publié: (2008)

Beta2-Agonists and Asthma in Children
par: Guy Lapierre
Publié: (1995-01-01)

Canadian Thoracic Society Asthma Committee Commentary on Long-Acting Beta-2 Agonist Use for Asthma in Canada
par: M Diane Lougheed, et autres
Publié: (2010-01-01)

Effect of 443c81, an inhaled mu-opioid receptor agonist in asthma.
par: Pavord, I, et autres
Publié: (1994)

Should ipratropium bromide be added to beta-agonists in treatment of acute severe asthma?
par: Higgins, R, et autres
Publié: (1988)

What Is the Role of Beta-Agonist Bronchodilators in the Day-to-Day Treatment of Chronic Asthma?
par: Pierre Ernst
Publié: (1995-01-01)

The Effect of Inhaled Beta-2 Agonists on Heart Rate in Patients With Asthma: Sensor-Based Observational Study
par: Rishi Jayant Khusial, et autres
Publié: (2024-12-01)

Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma.
par: Wong, C, et autres
Publié: (1990)

Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma
par: Crossingham, I, et autres
Publié: (2020)

The Relationship among the Inspiratory Muscle Strength, the Perception of Dyspnea and Inhaled Beta2-Agonists in Patients with Asthma
par: Paltiel Weiner, et autres
Publié: (2002-01-01)

Combination fixed‐dose beta agonist and steroid inhaler as required for adults or children with mild asthma
par: Crossingham, I, et autres
Publié: (2021)

Loss of Asthma Control in Pediatric Patients after Discontinuation of Long-Acting Beta-Agonists
par: Adrian R. O'Hagan, et autres
Publié: (2012-01-01)

Bronchodilator Responsiveness Measured by Spirometry and Impulse Oscillometry in Patients with Asthma After Short Acting Antimuscarinic and/or Beta-2-Agonists Inhalation
par: van der Burg NMD, et autres
Publié: (2024-01-01)

Cost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting β-agonists
par: Willson, J, et autres
Publié: (2014)

Cost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting β-agonists.
par: Willson, J, et autres
Publié: (2014)

The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis
par: Pavord, I, et autres
Publié: (2017)

Prescription of oral short-acting beta 2-agonist for asthma in non-resource poor settings: A national study in Malaysia
par: Chin, M.C., et autres
Publié: (2017)

Use of beta-2 agonists and risk of hip fracture
par: De Vries, F, et autres
Publié: (2006)

Effect of inhaled prostaglandin E2 on allergen-induced asthma.
par: Pavord, I, et autres
Publié: (1993)

A severe tremor caused by a beta2 agonist in a patient with asthma‐chronic obstructive pulmonary disease overlap
par: Kota Nakajima, et autres
Publié: (2024-08-01)

The role of polymorphic variants of arginase genes (<i>ARG1, ARG2</i>) involved in beta-2-agonist metabolism in the development and course of asthma
par: O. N. Savelieva, et autres
Publié: (2020-07-01)

The Asthma App as a New Way to Promote Responsible Short-Acting Beta2-Agonist Use in People With Asthma: Results of a Mixed Methods Pilot Study
par: Liselot N van den Berg, et autres
Publié: (2024-04-01)

Evaluation of short-acting Beta-2-agonist prescriptions and associated clinical outcomes: Findings from the SABA use IN Asthma (SABINA) study in Asia
par: Hao-Chien Wang, MD PhD, et autres
Publié: (2023-10-01)

Beta-adrenergic agonists and corticotropin secretion.
par: Al-Damluji, S, et autres
Publié: (1985)

Perceptions, practices, and experiences of asthma patients and community pharmacists on short-acting beta-2 agonists inhaler use: A qualitative study
par: Rabia Hussain, et autres
Publié: (2025-12-01)

Asthma phenotypes.
par: Pavord, I
Publié: (2012)

Cough and asthma.
par: Pavord, I
Publié: (2004)

Effect of beta 2-adrenoceptor agonists on serotonin biochemistry and function.
par: Green, A, et autres
Publié: (1984)

The Beta Agonist Lung Injury Trial Prevention
par: Perkins, G, et autres
Publié: (2014)

Treatment persistence and exacerbations in patients with asthma initiating treatment with inhaled corticosteroids and beta-adrenergic agonists: retrospective cohort study
par: Toni Fernández-Sánchez, et autres
Publié: (2022-04-01)

CRTH2 expression on T cells in asthma.
par: Mutalithas, K, et autres
Publié: (2010)

Asthma guidelines.
par: Green, R, et autres
Publié: (2000)

Short Acting Beta Agonist Use Associated with Increased Mortality and Morbidity in Asthma Patients: A Systematic Review and Meta-Analysis
par: Yiyun Hu, et autres
Publié: (2022-06-01)

COMPARISON OF ORAL AND LARYNGEAL FINDINGS OF ASTHMA PATIENTS USING DIFFERENT DRY POWDER INHALER DEVICES CONTAINING STEROID AND BETA AGONISTS
par: Fahrettin Talay, et autres
Publié: (2013-09-01)

Eosinophils in asthma and airway hyperresponsiveness.
par: Brightling, C, et autres
Publié: (2004)

Allosteric modulator potentiates β2AR agonist–promoted bronchoprotection in asthma models
par: Seungkirl Ahn, et autres
Publié: (2023-09-01)

Cough and asthma.
par: Berry, M, et autres
Publié: (2003)

The carbon footprint associated with the overuse of short-acting β2-agonists in asthma patients
par: Chao-Hsien Chen, et autres
Publié: (2024-01-01)